18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMBINED WITH COMPUTED TOMOGRAPHY IN EVALUATION OF EFFECTIVENESS OF TARGETED THERAPY OF RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER (CLINICAL OBSERVATION)

N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia; 24 Kashirskoe Shosse, Moscow 115478, Russia Positron emission tomography (PET) with 18F-fluorodeoxyglucose is included in the algorithm of examination and monitoring in patients with radioactive iodine-refractory d...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Odzharova, M. B. Dolgushin, A. M. Mudunov, I. S. Romanov, R. E. Tulin, D. I. Nevzorov
Format: Article
Language:Russian
Published: ABV-press 2017-11-01
Series:Опухоли головы и шеи
Subjects:
Online Access:https://ogsh.abvpress.ru/jour/article/view/295
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849401662790172672
author A. A. Odzharova
M. B. Dolgushin
A. M. Mudunov
I. S. Romanov
R. E. Tulin
D. I. Nevzorov
author_facet A. A. Odzharova
M. B. Dolgushin
A. M. Mudunov
I. S. Romanov
R. E. Tulin
D. I. Nevzorov
author_sort A. A. Odzharova
collection DOAJ
description N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia; 24 Kashirskoe Shosse, Moscow 115478, Russia Positron emission tomography (PET) with 18F-fluorodeoxyglucose is included in the algorithm of examination and monitoring in patients with radioactive iodine-refractory differentiated thyroid cancer. In assessing the effectiveness of targeted therapy, criteria based on the values of SUVmax (standardized uptake value) in metastases are used. The article shows the results of PET studies in a patient with radioactive iodine-refractory papillary thyroid cancer treated with sorafenib. The dynamics of tumor activity of metastases by different quantitative indicators were evaluated.
format Article
id doaj-art-e55c96cded574bd5803a011dfa8f2ac6
institution Kabale University
issn 2222-1468
2411-4634
language Russian
publishDate 2017-11-01
publisher ABV-press
record_format Article
series Опухоли головы и шеи
spelling doaj-art-e55c96cded574bd5803a011dfa8f2ac62025-08-20T03:37:43ZrusABV-pressОпухоли головы и шеи2222-14682411-46342017-11-017310310710.17650/2222-1468-2017-7-3-103-10726818F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMBINED WITH COMPUTED TOMOGRAPHY IN EVALUATION OF EFFECTIVENESS OF TARGETED THERAPY OF RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER (CLINICAL OBSERVATION)A. A. Odzharova0M. B. Dolgushin1A. M. Mudunov2I. S. Romanov3R. E. Tulin4D. I. Nevzorov5N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia.N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia.N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia.N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia.N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia.N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia.N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia; 24 Kashirskoe Shosse, Moscow 115478, Russia Positron emission tomography (PET) with 18F-fluorodeoxyglucose is included in the algorithm of examination and monitoring in patients with radioactive iodine-refractory differentiated thyroid cancer. In assessing the effectiveness of targeted therapy, criteria based on the values of SUVmax (standardized uptake value) in metastases are used. The article shows the results of PET studies in a patient with radioactive iodine-refractory papillary thyroid cancer treated with sorafenib. The dynamics of tumor activity of metastases by different quantitative indicators were evaluated.https://ogsh.abvpress.ru/jour/article/view/295differentiated thyroid cancerpositron emission tomography/computed tomographymetabolic tumor volume and total lesion glycolysissorafenib
spellingShingle A. A. Odzharova
M. B. Dolgushin
A. M. Mudunov
I. S. Romanov
R. E. Tulin
D. I. Nevzorov
18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMBINED WITH COMPUTED TOMOGRAPHY IN EVALUATION OF EFFECTIVENESS OF TARGETED THERAPY OF RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER (CLINICAL OBSERVATION)
Опухоли головы и шеи
differentiated thyroid cancer
positron emission tomography/computed tomography
metabolic tumor volume and total lesion glycolysis
sorafenib
title 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMBINED WITH COMPUTED TOMOGRAPHY IN EVALUATION OF EFFECTIVENESS OF TARGETED THERAPY OF RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER (CLINICAL OBSERVATION)
title_full 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMBINED WITH COMPUTED TOMOGRAPHY IN EVALUATION OF EFFECTIVENESS OF TARGETED THERAPY OF RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER (CLINICAL OBSERVATION)
title_fullStr 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMBINED WITH COMPUTED TOMOGRAPHY IN EVALUATION OF EFFECTIVENESS OF TARGETED THERAPY OF RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER (CLINICAL OBSERVATION)
title_full_unstemmed 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMBINED WITH COMPUTED TOMOGRAPHY IN EVALUATION OF EFFECTIVENESS OF TARGETED THERAPY OF RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER (CLINICAL OBSERVATION)
title_short 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMBINED WITH COMPUTED TOMOGRAPHY IN EVALUATION OF EFFECTIVENESS OF TARGETED THERAPY OF RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER (CLINICAL OBSERVATION)
title_sort 18f fluorodeoxyglucose positron emission tomography combined with computed tomography in evaluation of effectiveness of targeted therapy of radioactive iodine refractory differentiated thyroid cancer clinical observation
topic differentiated thyroid cancer
positron emission tomography/computed tomography
metabolic tumor volume and total lesion glycolysis
sorafenib
url https://ogsh.abvpress.ru/jour/article/view/295
work_keys_str_mv AT aaodzharova 18ffluorodeoxyglucosepositronemissiontomographycombinedwithcomputedtomographyinevaluationofeffectivenessoftargetedtherapyofradioactiveiodinerefractorydifferentiatedthyroidcancerclinicalobservation
AT mbdolgushin 18ffluorodeoxyglucosepositronemissiontomographycombinedwithcomputedtomographyinevaluationofeffectivenessoftargetedtherapyofradioactiveiodinerefractorydifferentiatedthyroidcancerclinicalobservation
AT ammudunov 18ffluorodeoxyglucosepositronemissiontomographycombinedwithcomputedtomographyinevaluationofeffectivenessoftargetedtherapyofradioactiveiodinerefractorydifferentiatedthyroidcancerclinicalobservation
AT isromanov 18ffluorodeoxyglucosepositronemissiontomographycombinedwithcomputedtomographyinevaluationofeffectivenessoftargetedtherapyofradioactiveiodinerefractorydifferentiatedthyroidcancerclinicalobservation
AT retulin 18ffluorodeoxyglucosepositronemissiontomographycombinedwithcomputedtomographyinevaluationofeffectivenessoftargetedtherapyofradioactiveiodinerefractorydifferentiatedthyroidcancerclinicalobservation
AT dinevzorov 18ffluorodeoxyglucosepositronemissiontomographycombinedwithcomputedtomographyinevaluationofeffectivenessoftargetedtherapyofradioactiveiodinerefractorydifferentiatedthyroidcancerclinicalobservation